NewAmsterdam Pharma Co. NV (NAMS)
22.43
+0.16
(+0.72%)
USD |
NASDAQ |
Oct 07, 11:15
NewAmsterdam Pharma Profit Margin (Quarterly) : -1.73K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.73K% |
| March 31, 2026 | -1.59K% |
| December 31, 2025 | -234.1K% |
| September 30, 2025 | -20.69K% |
| June 30, 2025 | -90.70% |
| Date | Value |
|---|---|
| March 31, 2025 | -1.33K% |
| December 31, 2024 | -721.7% |
| September 30, 2024 | -57.18% |
| June 30, 2024 | -1.71K% |
| March 31, 2024 | -6.69K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ProQR Therapeutics NV | -99.65% |
| Pharming Group NV | 1.77% |
| argenx SE | -- |
| Ionis Pharmaceuticals, Inc. | -42.79% |
| Arcutis Biotherapeutics, Inc. | 11.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.21% |
| Return on Assets | -34.07% |
| Return on Invested Capital | -37.20% |
| Gross Profit Margin (Quarterly) | 98.41% |
| Operating Margin (Quarterly) | -1.75K% |
| Return on Net Operating Assets | -1.87K% |